This is a preview of subscription content, log in via an institution to check access.
References
1. Meiri A, et al. Trends in Insulin Out-of-Pocket Costs and Reimbursement Price Among US Patients With Private Health Insurance, 2006-2017. JAMA Internal Medicine : Jun 2020. Available from: URL: http://doi.org/10.1001/jamainternmed.2020.1302
2. Chua KP, et al. Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes. JAMA Internal Medicine : Jun 2020. Available from: URL: http://doi.org/10.1001/jamainternmed.2020.1308
3. Nally LM, et al. Expensive Insulin-The Epicenter of a Large, Life-Threatening Problem. JAMA Internal Medicine : 1 Jun 2020. Available from: URL: http://dx.do.org/10.1001/jamainternmed.2020.1299
Rights and permissions
About this article
Cite this article
High out-of-pocket cost burden for insulin in privately insured US patients. PharmacoEcon Outcomes News 855, 18 (2020). https://doi.org/10.1007/s40274-020-6883-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6883-5